Fielmann AG
OTC:FLMNF
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
Fielmann AG
OTC:FLMNF
|
DE |
|
Dermata Therapeutics Inc
NASDAQ:DRMA
|
US |
|
Deutsche Telekom AG
MIL:DTE
|
DE |
|
DURECT Corp
NASDAQ:DRRX
|
US |
|
FINEOS Corporation Holdings PLC
ASX:FCL
|
IE |
|
B
|
Business First Bancshares Inc
NASDAQ:BFST
|
US |
|
C
|
CAP SA
SGO:CAP
|
CL |
|
Y
|
Y Optics Manufacture Co Ltd
KOSDAQ:066430
|
KR |
|
PostNL NV
AEX:PNL
|
NL |
|
Nextracker Inc
NASDAQ:NXT
|
US |
|
Mersen SA
PAR:MRN
|
FR |
|
S
|
Siemens AG
SWB:SIE
|
DE |
|
A
|
Astrocast SA
OSE:ASTRO
|
CH |
Wall Street
Price Targets
FLMNF Price Targets Summary
Fielmann AG
According to Wall Street analysts, the average 1-year price target for
FLMNF
is 75.43 USD
with a low forecast of 65.49 USD and a high forecast of 91.2 USD.
Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What is available on other sites you are seeing are mostly from the sell-side analysts.
What is FLMNF's stock price target?
Price Target
75.43
USD
According to Wall Street analysts, the average 1-year price target for
FLMNF
is 75.43 USD
with a low forecast of 65.49 USD and a high forecast of 91.2 USD.
What is Fielmann AG's Revenue forecast?
Projected CAGR
7%
For the last 13 years the
compound annual growth rate for
Fielmann AG's revenue is
6%.
The projected
CAGR
for the next 4 years is
7%.
What is Fielmann AG's Operating Income forecast?
Projected CAGR
14%
For the last 13 years the
compound annual growth rate for
Fielmann AG's operating income is
3%.
The projected
CAGR
for the next 4 years is
14%.
What is Fielmann AG's Net Income forecast?
Projected CAGR
19%
For the last 13 years the
compound annual growth rate for
Fielmann AG's net income is
2%.
The projected
CAGR
for the next 3 years is
19%.
